Literature DB >> 14568128

Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism.

George P Paraskevas1, Elisabeth Kapaki, Olga Petropoulou, Maria Anagnostouli, Vasileios Vagenas, Constantine Papageorgiou.   

Abstract

Oxidative stress is an important mechanism of cell death in Parkinson's disease (PD) and brain ischemia. Vitamins C, E and A are important antioxidants and deficiency of these agents has been implicated in the mechanisms of atherosclerosis. We measured the levels of the above antioxidant vitamins in 44 patients with PD, 12 patients with vascular parkinsonism (VP), 11 patients with other parkinsonism syndromes of various causes and 39 controls. Vitamin A levels did not differ between groups. Vitamins C and E were found decreased in VP, while they were normal in PD indicating low levels of antioxidant vitamins in VP and stressing the necessity of maintaining sufficient dietary intake of these agents in the elderly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568128     DOI: 10.1016/s0022-510x(03)00184-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line.

Authors:  Alice Kunzler; Eduardo Antônio Kolling; Jeferson Delgado da Silva; Juciano Gasparotto; Matheus Augusto de Bittencourt Pasquali; José Cláudio Fonseca Moreira; Daniel Pens Gelain
Journal:  Neurochem Res       Date:  2017-05-11       Impact factor: 3.996

2.  The promise of neuroprotective agents in Parkinson's disease.

Authors:  Stacey E Seidl; Judith A Potashkin
Journal:  Front Neurol       Date:  2011-11-21       Impact factor: 4.003

3.  Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.

Authors:  Muhammad Usman Mirza; A Hammad Mirza; Noor-Ul-Huda Ghori; Saba Ferdous
Journal:  Drug Des Devel Ther       Date:  2014-12-18       Impact factor: 4.162

4.  Vitamin C is a source of oxoaldehyde and glycative stress in age-related cataract and neurodegenerative diseases.

Authors:  Xingjun Fan; David R Sell; Caili Hao; Sabrina Liu; Benlian Wang; Daniel W Wesson; Sandra Siedlak; Xiongwei Zhu; Terrance J Kavanagh; Fiona E Harrison; Vincent M Monnier
Journal:  Aging Cell       Date:  2020-06-21       Impact factor: 9.304

Review 5.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

Review 6.  Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.

Authors:  Samantha Giordano; Victor Darley-Usmar; Jianhua Zhang
Journal:  Redox Biol       Date:  2013-12-25       Impact factor: 11.799

Review 7.  The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson's Disease.

Authors:  Minrui Weng; Xiaoji Xie; Chao Liu; Kah-Leong Lim; Cheng-Wu Zhang; Lin Li
Journal:  Parkinsons Dis       Date:  2018-09-02

8.  Neuroprotective Activities of Boophone haemanthoides (Amaryllidaceae) Extract and Its Chemical Constituents.

Authors:  Abobaker S Ibrakaw; Sylvester I Omoruyi; Okobi E Ekpo; Ahmed A Hussein
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

Review 9.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

10.  Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.

Authors:  Carmen Costas; Lilian R F Faro
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.